Curis
CRIS
#10201
Rank
S$22.61 M
Marketcap
S$1.75
Share price
0.00%
Change (1 day)
-66.91%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -S$42.89 Million

According to Curis's latest financial reports the company's current earnings are S$11.65 Million. In 2024 the company made an earning of -S$55.44 Million, an increase over its 2023 earnings that were of -S$58.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$42.89 Million-22.64%
2024 -S$55.44 Million-5.77%
2023 -S$58.83 Million-13.1%
2022 -S$67.7 Million27.52%
2021 -S$53.09 Million65.09%
2020 -S$32.16 Million-9.1%
2019 -S$35.38 Million-4.73%
2018 -S$37.13 Million-41.95%
2017 -S$63.96 Million-14.37%
2016 -S$74.69 Million3.55%
2015 -S$72.13 Million271.52%
2014 -S$19.42 Million76.64%
2013 -S$11 Million
2011 -S$9.34 Million27.76%
2010 -S$7.31 Million-43.87%
2009 -S$13.02 Million-23.44%
2008 -S$17.01 Million56.66%
2007 -S$10.86 Million-16.71%
2006 -S$13.04 Million-36.92%
2005 -S$20.66 Million156.25%
2004 -S$8.07 Million-37.24%
2003 -S$12.85 Million-93.34%
2002 -S$0.2 Billion86.79%
2001 -S$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Exelixis
EXEL
S$1.13 B-2,782.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.21 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-S$80.2 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.34 Billion 687.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.35 B-36,502.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.40 B-24,772.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-S$32.05 Million-24.06%๐Ÿ‡บ๐Ÿ‡ธ USA